Our latest AMJ Rheumatology Journal is now live with ACR 2025 coverage. Discover the shift toward earlier, mechanism-based treatments that reduce steroid dependence and protect long-term organ health. See how CAR-T therapy is evolving from cancer care to potentially resetting the immune system in refractory lupus. Plus, explore an unexpected vasculitis case that started with blue toes.
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.





